August 27, 2014 5:05 PM ET

Pharmaceuticals

Company Overview of ViroChem Pharma, Inc.

Company Overview

ViroChem Pharma, Inc. engages in researching, developing, and producing drugs for viral diseases. It offers drugs for HCV and HIV infections. The company’s lab facilities are located in Montreal, Canada. ViroChem Pharma, Inc. was founded in 2004 and is based in Laval, Canada. As of March 12, 2009, ViroChem Pharma, Inc. operates as a subsidiary of Vertex Pharmaceuticals Incorporated.

275 Armand-Frappier Boulvard

Laval, QC H7V 4A7

Canada

Founded in 2004

Phone:

450-978-7700

Fax:

450-978-7777

Key Executives for ViroChem Pharma, Inc.

ViroChem Pharma, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Taro Pharmaceuticals Inc. Americas
Le Groupe M. Vachon, Inc. Americas
Global IQ, Inc. Americas
VESPA Power Products, LLC Americas
In the Zone Produce Ltd. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ViroChem Pharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.